日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

A CNN-Based Model of Cross-Immunity to Influenza A(H3N2) Virus: Testing Under "Real-World" Conditions

基于卷积神经网络的甲型H3N2流感病毒交叉免疫模型：在“真实世界”条件下的测试

期刊:Viruses-Basel
影响因子:3.5
doi:10.3390/v18030327
Asatryan, Marina N; Agasaryan, Vaagn G; Timofeev, Boris I; Shmyr, Ilya S; Shcherbinin, Dmitrii N; Gerasimuk, Elita R; Timofeeva, Tatiana A; Ershov, Ivan F; Semenenko, Tatiana A; Logunov, Denis Yu; Gintsburg, Alexander L
微生物学
流感
免疫/内分泌
发表日期：2026
文献求助 收藏

Patient Perceptions of a Financial Resource Handout Following Gynecologic Cancer Diagnosis: A Mixed-Methods Study of Feasibility and Patient-Reported Utility

妇科癌症诊断后患者对经济资源手册的看法：一项关于可行性和患者报告效用的混合方法研究

期刊:Cureus Journal of Medical Science
影响因子:1.3
doi:10.7759/cureus.104373
Levine, Arielle R; Liu, Chrissy; Harold, Justin; McNamara, Blair; Andikyan, Vaagn
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

PARP Inhibitors in Ovarian Cancer: Resistance Mechanisms, Clinical Evidence, and Evolving Strategies

卵巢癌中的PARP抑制剂：耐药机制、临床证据和不断发展的策略

期刊:Biomedicines
影响因子:3.9
doi:10.3390/biomedicines13051126
Apelian, Shant; Martincuks, Antons; Whittum, Michelle; Yasukawa, Maya; Nguy, Lindsey; Mathyk, Begum; Andikyan, Vaagn; Anderson, Matthew L; Rutherford, Thomas; Cristea, Mihaela; Stewart, Daphne; Kohut, Adrian
PARP
肿瘤
肿瘤免疫
卵巢癌
发表日期：2025
文献求助 收藏

Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix

子宫颈低分化高级别神经内分泌癌的整合突变图谱分析

期刊:Proceedings of the National Academy of Sciences of the United States of America
影响因子:9.1
doi:10.1073/pnas.2321898121
Bellone, Stefania; Jeong, Kyungjo; Halle, Mari Kyllesø; Krakstad, Camilla; McNamara, Blair; Greenman, Michelle; Mutlu, Levent; Demirkiran, Cem; Hartwich, Tobias Max Philipp; Yang-Hartwich, Yang; Zipponi, Margherita; Buza, Natalia; Hui, Pei; Raspagliesi, Francesco; Lopez, Salvatore; Paolini, Biagio; Milione, Massimo; Perrone, Emanuele; Scambia, Giovanni; Altwerger, Gary; Ravaggi, Antonella; Bignotti, Eliana; Huang, Gloria S; Andikyan, Vaagn; Clark, Mitchell; Ratner, Elena; Azodi, Masoud; Schwartz, Peter E; Quick, Charles M; Angioli, Roberto; Terranova, Corrado; Zaidi, Samir; Nandi, Shuvro; Alexandrov, Ludmil B; Siegel, Eric R; Choi, Jungmin; Schlessinger, Joseph; Santin, Alessandro D
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Correction: Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer

更正：一项随机II期临床试验，研究每周一次伊沙匹隆联合或不联合每两周一次贝伐珠单抗治疗铂类耐药或难治性卵巢癌/输卵管癌/原发性腹膜癌的疗效。

期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/s41416-024-02628-4
Roque, Dana M; Siegel, Eric R; Buza, Natalia; Bellone, Stefania; Silasi, Dan-Arin; Huang, Gloria S; Andikyan, Vaagn; Clark, Mitchell; Azodi, Masoud; Schwartz, Peter E; Rao, Gautam G; Reader, Jocelyn C; Hui, Pei; Tymon-Rosario, Joan R; Harold, Justin; Mauricio, Dennis; Zeybek, Burak; Menderes, Gulden; Altwerger, Gary; Ratner, Elena; Santin, Alessandro D
肿瘤
肿瘤免疫
卵巢癌
发表日期：2024
文献求助 收藏

Uterine teratoma and the role of short-tandem repeat genotyping in understanding origins

子宫畸胎瘤及短串联重复序列基因分型在理解其起源中的作用

期刊:Gynecologic Oncology Reports
影响因子:1.3
doi:10.1016/j.gore.2024.101652
AlAshqar, Abdelrahman; Kadam Maruthi, Vijaya; Abi-Raad, Rita; Greenman, Michelle; Hui, Pei; Ratner, Elena; Altwerger, Gary; Santin, Alessandro; Andikyan, Vaagn
发表日期：2024
文献求助 收藏

Randomized phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer (NCT03093155): Updated survival and subgroup analyses

一项针对铂类耐药或难治性卵巢癌/输卵管癌/原发性腹膜癌的随机II期试验，比较每周一次伊沙匹隆±每两周一次贝伐珠单抗的疗效（NCT03093155）：更新的生存率和亚组分析

期刊:
影响因子:
doi:10.1038/s44276-024-00067-5
Roque, Dana M; Siegel, Eric R; Buza, Natalia; Bellone, Stefania; Huang, Gloria S; Altwerger, Gary; Andikyan, Vaagn; Clark, Mitchell; Azodi, Masoud; Schwartz, Peter E; Rao, Gautam G; Ratner, Elena; Santin, Alessandro D
肿瘤
肿瘤免疫
卵巢癌
发表日期：2024
文献求助 收藏

In Vivo and In Vitro Efficacy of Trastuzumab Deruxtecan in Uterine Serous Carcinoma

曲妥珠单抗德鲁西替康治疗子宫浆液性癌的体内外疗效

期刊:Molecular Cancer Therapeutics
影响因子:5.5
doi:10.1158/1535-7163.MCT-23-0126
Mutlu, Levent; Manavella, Diego D; Bellone, Stefania; McNamara, Blair; Harold, Justin A; Mauricio, Dennis; Siegel, Eric R; Buza, Natalia; Hui, Pei; Hartwich, Tobias Max Philipp; Yang-Hartwich, Yang; Demirkiran, Cem; Verzosa, Miguel Skyler Z; Altwerger, Gary; Ratner, Elena S; Huang, Gloria S; Clark, Mitchell; Andikyan, Vaagn; Azodi, Masoud; Dottino, Peter R; Schwartz, Peter E; Santin, Alessandro D
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Uterine leiomyosarcomas harboring MAP2K4 gene amplification are sensitive in vivo to PLX8725, a novel MAP2K4 inhibitor

携带 MAP2K4 基因扩增的子宫平滑肌肉瘤在体内对新型 MAP2K4 抑制剂 PLX8725 敏感

期刊:Gynecologic Oncology
影响因子:4.5
doi:10.1016/j.ygyno.2023.03.009
Blair McNamara, Justin Harold, Diego Manavella, Stefania Bellone, Levent Mutlu, Tobias Max Philipp Hartwich, Margherita Zipponi, Yang Yang-Hartwich, Cem Demirkiran, Miguel Skyler Z Verzosa, Kevin Yang, Jungmin Choi, Weilai Dong, Natalia Buza, Pei Hui, Gary Altwerger, Gloria S Huang, Vaagn Andikyan, 
肿瘤
发表日期：2023
文献求助 收藏

The Poly (ADP-ribose) polymerase inhibitor olaparib and pan-ErbB inhibitor neratinib are highly synergistic in HER2 overexpressing epithelial ovarian carcinoma in vitro and in vivo

聚（ADP-核糖）聚合酶抑制剂奥拉帕尼和泛 ErbB 抑制剂来那替尼在体外和体内对 HER2 过度表达的上皮性卵巢癌具有高度协同作用

期刊:Gynecologic Oncology
影响因子:4.5
doi:10.1016/j.ygyno.2023.01.015
Chanhee Han, Blair McNamara, Stefania Bellone, Justin Harold, Paola Manara, Tobias Max Philipp Hartwich, Levent Mutlu, Yang Yang-Hartwich, Margherita Zipponi, Cem Demirkiran, Miguel Skyler Z Verzosa, Gary Altwerger, Elena Ratner, Gloria S Huang, Mitchell Clark, Vaagn Andikyan, Masoud Azodi, Peter R
肿瘤
卵巢癌
发表日期：2023
文献求助 收藏